Alterity Therapeutics Limited - American Depositary Shares (ATHE)

Alterity Therapeutics is a biotechnology company focused on the development of innovative therapies to address neurodegenerative diseases

The company is dedicated to advancing treatments for conditions such as Alzheimer’s disease and other disorders that affect the nervous system. Through its research and clinical programs, Alterity aims to discover and commercialize novel approaches that can improve patient outcomes and enhance quality of life for those affected by these challenging conditions. The company emphasizes a science-driven strategy, leveraging cutting-edge discoveries to address unmet medical needs in the field of neurology.